661 University Avenue
Toronto ON M5G1M1
- A highly competitive salary, health and dental benefits, and meaningful equity compensation.
- Exceptional opportunities for learning and growth.
- A collegial working environment with regular social events for team members and their families.
- You’ll also be joining a bright and highly-motivated team working at the intersection of the most exciting areas of science and technology.
We are seeking an ambitious and talented molecular biologist, who is familiar with oligonucleotide chemistries, to help us develop oligonucleotide therapies for rare diseases. This ideal candidate will lead the research and development of novel approaches to use oligonucleotides therapeutically and methods to characterize oligonucleotides and their effects in biological systems. They will have a flexible attitude to job roles and superlative organizational, interpersonal, and communication skills.
- PhD in the biological sciences or chemistry with at least 2 years of postgraduate experience, preferably in biotechnology or a pharmaceutical industry setting
- Extensive experience with oligonucleotides and standard techniques in molecular and cell biology including, for example, DNA/RNA/Protein isolation and analysis, genetic manipulation of mammalian cells (e.g. CRISPR/Cas9), flow cytometry, etc.
- Previous experience working with any / all of the following is desirable: collaborated with oligonucleotide CROs and cellular/animal models of mendelian disorders
- Comfortable working with limited supervision in a fast-paced and rapidly growing work environment
How to Apply
To apply for this position, please click on the below link:
About Our Organization
Deep Genomics is a Toronto-based startup company that is building an AI-powered discovery and development platform to significantly expand the universe of medicines available for genetically-defined diseases. Founded in 2015, Deep Genomics brings together a multidisciplinary team of world-leading experts in machine learning, genomics, chemistry, and biology. Together we are on a mission to rapidly discover and develop oligonucleotide drugs for the treatment of patients with severe disorders of the liver, central nervous system, and eye.